The American Society of Clinical Oncology (ASCO), over 25,000 members strong, includes representatives from all areas of cancer care:... Read more »
Question: Are there currently any clinical trials for premenopausal women/women diagnosed under 40 on the use of aromatase inhibitors vs.... Read more »
Tamoxifen, or Arimidex/Aromasin/Femara? Which one’s going to keep my cancer from coming back? After years of rumor and equivocation, the... Read more »
Earlier this summer, the National Institutes of Health decided not to fund a breast cancer prevention trial to test Letrozole (Femara), an... Read more »
A recent study of breast cancer patients showed that about a third of women stopped taking their tamoxifen (nolvadex) before the end of the... Read more »
Source: Breastcancer.org
Aromatase inhibitors stop the production of estrogen in post-menopausal women. Aromatase inhibitors work by blocking the enzyme aromatase, which... Read more »
Source: Breastcancer.org
Tamoxifen, the generic name of Nolvadex, is the oldest and most-prescribed SERM. Tamoxifen is approved by the U.S. Food and Drug Administration (FDA)... Read more »